Obesity induced by high calorie/fat diet and physical inactivity can result in serious health problems including chronic diseases such as cardiovascular disease and type 2 diabetes, which are associated with insulin resistance. , 2) increased mitochondrial overload and incomplete fatty acid oxidation 5 , and 3) increased mitochondrial oxidative stress (e.g., H2O2) in skeletal muscle. suggesting that estrogen treatment might protect against the risk of type 2 diabetes and metabolic syndrome in postmenopausal women with estrogen deficiency. The findings are very interesting and therapeutically significant in obesity, type 2 diabetes, and metabolic syndrome. This study suggests AMPK as a highly attractive target for the development of strategies to curb the prevalence and costs of obesity and type 2 diabetes. However, they could not determine the potential mechanism(s) through which 17beta-estradiol stimulated the expression of genes associated with glucose uptake in C2C12 myotubes.
Insulin resistance can affect skeletal muscle, liver, β-cells, fat cells, the gastrointestinal track, kidneys, and brain. 2 Among these, skeletal muscle insulin resistance caused by obesity or type 2 diabetes is manifested as decreased glucose uptake because skeletal muscle comprises 40-50% of the total human body mass. It has been demonstrated by numerous studies that skeletal muscle insulin resistance is associated with mitochondrial dysfunction including 1) reduced fatty acid oxidation and increased accumulation of lipid intermediates (e.g., FA-CoA, DAG, ceramide) 3, 4 , 2) increased mitochondrial overload and incomplete fatty acid oxidation 5 , and 3) increased mitochondrial oxidative stress (e.g., H2O2) in skeletal muscle. 6, 7 Lee et al. Furthermore, emerging evidence indicates that overnutrition results in elevated mitochondrial oxidative stress (i.e., reactive oxygen species; ROS), which is the primary factor in the development of insulin resistance in skeletal muscle. 6, 7 Therefore, the authors note that they will investigate the role of estrogen and mitochondria, which is associated with glucose uptake in skeletal muscle. Moreover, the effects of estrogen on obesity-induced insulin resistance in skeletal muscle should be determined as a future direction.
One more intriguing part in this study is that 17beta-estradiol treatment stimulates the upregulation of ACC, CPT1, UCP2 as well as AMPK in C2C12 myotubes, which are associated with fatty acid oxidation. It is well known that one of the important pathways in AMPK's regulation of fatty acid metabolism is the phosphorylation and inhibition of ACC. ACC converts acetyl-CoA to maloylCoA, an inhibitor of CPT-1. 10 Therefore, we expect that 17beta-estradiol treatment may phosphorylate both AMPK and ACC, and the inactivation of ACC may result in increased CPT-1, leading to improved fatty acid transport in mitochondria and subsequent fatty acid oxidation. Accordingly, the authors should measure the effects of estrogen on fatty acid oxidation in skeletal muscle to determine the role of estrogen in the fatty acid oxidation pathway.
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